Novo Integrated Sciences Net Income 2012-2024 | NVOS
Novo Integrated Sciences net income from 2012 to 2024. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
|
Novo Integrated Sciences Annual Net Income (Millions of US $) |
|
|---|---|
| 2024 | $-16 |
| 2023 | $-13 |
| 2022 | $-33 |
| 2021 | $-4 |
| 2020 | $-5 |
| 2019 | $0 |
| 2018 | $-2 |
| 2017 | $-1 |
| 2016 | $0 |
| 2016 | $0 |
| 2015 | $-3 |
| 2014 | $-1 |
| 2013 | $-1 |
| 2012 | $-1 |
| 2012 | $-1 |
| 2011 | $-2 |
| 2011 | $-2 |
|
Novo Integrated Sciences Quarterly Net Income (Millions of US $) |
|
|---|---|
| 2024-08-31 | $5 |
| 2024-05-31 | $-14 |
| 2024-02-29 | $-3 |
| 2023-11-30 | $-5 |
| 2023-08-31 | $-3 |
| 2023-05-31 | $-1 |
| 2023-02-28 | $-5 |
| 2022-11-30 | $-4 |
| 2022-08-31 | $-22 |
| 2022-05-31 | $-4 |
| 2022-02-28 | $-5 |
| 2021-11-30 | $-2 |
| 2021-08-31 | $-2 |
| 2021-05-31 | $0 |
| 2021-02-28 | $-1 |
| 2020-11-30 | $-1 |
| 2020-08-31 | $-4 |
| 2020-05-31 | $0 |
| 2020-02-29 | $-1 |
| 2019-11-30 | $0 |
| 2019-08-31 | $0 |
| 2019-05-31 | $0 |
| 2019-02-28 | $0 |
| 2018-11-30 | $0 |
| 2018-08-31 | $0 |
| 2018-05-31 | $0 |
| 2018-02-28 | $-1 |
| 2017-11-30 | $0 |
| 2017-08-31 | $-1 |
| 2017-05-31 | $0 |
| 2017-03-31 | $0 |
| 2017-02-28 | $0 |
| 2016-12-31 | |
| 2016-11-30 | $0 |
| 2016-09-30 | $0 |
| 2016-06-30 | $0 |
| 2016-05-31 | $0 |
| 2016-03-31 | $0 |
| 2015-12-31 | |
| 2015-09-30 | $0 |
| 2015-06-30 | $0 |
| 2015-03-31 | $-2 |
| 2014-12-31 | |
| 2014-09-30 | $0 |
| 2014-06-30 | $0 |
| 2014-03-31 | $0 |
| 2013-12-31 | |
| 2013-09-30 | $0 |
| 2013-06-30 | $0 |
| 2013-03-31 | $0 |
| 2012-12-31 | $0 |
| 2012-09-30 | $0 |
| 2012-08-31 | |
| 2012-06-30 | $0 |
| 2012-03-31 | $0 |
| 2012-02-29 | $0 |
| 2011-12-31 | |
| 2011-11-30 | $-1 |
| 2011-09-30 | $-1 |
| 2011-08-31 | $0 |
| 2011-06-30 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $0.000B | $0.013B |
| Novo Integrated Sciences Inc. is a provider of multi-dimensional primary healthcare services and products principally in Canada and the U.S. It deliver or intend to deliver, multidisciplinary primary health care related services and products through the integration of medical technology, advanced therapeutics and rehabilitative science, through its subsidiaries. Novo Integrated Sciences Inc. is based in Bellevue, Washington. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $29.514B | 13.37 |
| Quest Diagnostics (DGX) | United States | $21.197B | 19.44 |
| Elanco Animal Health (ELAN) | United States | $11.500B | 24.35 |
| Encompass Health (EHC) | United States | $10.662B | 19.64 |
| DaVita (DVA) | United States | $10.023B | 13.82 |
| Chemed (CHE) | United States | $5.639B | 19.57 |
| Option Care Health (OPCH) | United States | $4.553B | 18.71 |
| RadNet (RDNT) | United States | $4.302B | 142.13 |
| LifeStance Health (LFST) | United States | $2.495B | 320.00 |
| Addus HomeCare (ADUS) | United States | $1.719B | 16.61 |
| Astrana Health (ASTH) | United States | $1.536B | 31.40 |
| Aveanna Healthcare Holdings (AVAH) | United States | $1.353B | 12.20 |
| U.S Physical Therapy (USPH) | United States | $1.157B | 29.19 |
| Pennant (PNTG) | United States | $1.072B | 31.31 |
| Daxor (DXR) | United States | $0.048B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.032B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |